The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein - PubMed (original) (raw)
. 2000 Mar 31;275(13):9163-9.
doi: 10.1074/jbc.275.13.9163.
Affiliations
- PMID: 10734051
- DOI: 10.1074/jbc.275.13.9163
Free article
The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein
A Boullier et al. J Biol Chem. 2000.
Free article
Abstract
There is growing evidence that CD36 has an important physiological function in the uptake of oxidized low density lipoprotein (OxLDL) by macrophages. However, the ligand specificity and the nature of the ligands on OxLDL that mediate the binding to CD36 remain ill defined. Results from recent studies suggested that some of the macrophage scavenger receptors involved in the uptake of OxLDL recognized both the lipid and the protein moieties of OxLDL, but there was no conclusive direct evidence for this. The present studies were undertaken to test whether a single, well characterized OxLDL receptor, CD36, could bind both the lipid and protein moieties of OxLDL. COS-7 cells transiently transfected with mouse CD36 cDNA bound intact OxLDL with high affinity. This binding was very effectively inhibited ( approximately 50%) both by the reconstituted apoB from OxLDL and by microemulsions prepared from OxLDL lipids. The specific binding of both moieties to CD36 was further confirmed by direct ligand binding analysis and by demonstrating reciprocal inhibition, i.e. apoB from OxLDL inhibited the binding of the OxLDL lipids and vice versa. Furthermore, a monoclonal mouse antibody that recognizes oxidation-specific epitopes in OxLDL inhibited the binding of intact OxLDL and also that of its purified protein and lipid moieties to CD36. This antibody recognizes the phospholipid 1-palmitoyl 2-(5'-oxovaleroyl) phosphatidylcholine. This model of an oxidized phospholipid was also an effective competitor for the CD36 binding of both the resolubilized apoB and the lipid microemulsions from OxLDL. Our results demonstrate that oxidized phospholipids in the lipid phase or covalently attached to apoB serve as ligands for recognition by CD36 and, at least in part, mediate the high affinity binding of OxLDL to macrophages.
Similar articles
- Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells.
Bird DA, Gillotte KL, Hörkkö S, Friedman P, Dennis EA, Witztum JL, Steinberg D. Bird DA, et al. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6347-52. doi: 10.1073/pnas.96.11.6347. Proc Natl Acad Sci U S A. 1999. PMID: 10339590 Free PMC article. - Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor.
Podrez EA, Hoppe G, O'Neil J, Hoff HF. Podrez EA, et al. Free Radic Biol Med. 2003 Feb 1;34(3):356-64. doi: 10.1016/s0891-5849(02)01294-7. Free Radic Biol Med. 2003. PMID: 12543251 - Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
Guy RA, Maguire GF, Crandall I, Connelly PW, Kain KC. Guy RA, et al. Atherosclerosis. 2001 Mar;155(1):19-28. doi: 10.1016/s0021-9150(00)00524-4. Atherosclerosis. 2001. PMID: 11223422 - Scavenger receptors, oxidized LDL, and atherosclerosis.
Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K, Hörkkö S, Palinski W, Quehenberger O, Shaw P, Steinberg D, Terpstra V, Witztum JL. Boullier A, et al. Ann N Y Acad Sci. 2001 Dec;947:214-22; discussion 222-3. doi: 10.1111/j.1749-6632.2001.tb03943.x. Ann N Y Acad Sci. 2001. PMID: 11795269 Review. - Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance.
Xia L, Zhou Z, Chen X, Luo W, Ding L, Xie H, Zhuang W, Ni K, Li G. Xia L, et al. Biomed Pharmacother. 2023 Dec;168:115834. doi: 10.1016/j.biopha.2023.115834. Epub 2023 Nov 6. Biomed Pharmacother. 2023. PMID: 37931517 Review.
Cited by
- Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response.
Hazen SL, Chisolm GM. Hazen SL, et al. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12515-7. doi: 10.1073/pnas.212532799. Epub 2002 Sep 23. Proc Natl Acad Sci U S A. 2002. PMID: 12271150 Free PMC article. No abstract available. - N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.
Ahmed KA, Muniandy S, Ismail IS. Ahmed KA, et al. J Clin Biochem Nutr. 2009 Jan;44(1):14-27. doi: 10.3164/jcbn.08-190. Epub 2008 Dec 27. J Clin Biochem Nutr. 2009. PMID: 19177184 Free PMC article. - Membrane Dynamics and Cation Handling in Ferroptosis.
Hirata Y, Mishima E. Hirata Y, et al. Physiology (Bethesda). 2024 Mar 1;39(2):73-87. doi: 10.1152/physiol.00029.2023. Epub 2024 Jan 9. Physiology (Bethesda). 2024. PMID: 38193763 Free PMC article. Review. - Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies.
Laera N, Malerba P, Vacanti G, Nardin S, Pagnesi M, Nardin M. Laera N, et al. Life (Basel). 2023 Oct 27;13(11):2128. doi: 10.3390/life13112128. Life (Basel). 2023. PMID: 38004268 Free PMC article. Review. - Approaches to Visualising Endocytosis of LDL-Related Lipoproteins.
Siddiqui H, Yevstigneyev N, Madani G, McCormick S. Siddiqui H, et al. Biomolecules. 2022 Jan 18;12(2):158. doi: 10.3390/biom12020158. Biomolecules. 2022. PMID: 35204658 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous